Statistics

Total Visits

Views
Long-Term (52-Week) Results Of a Phase 3, Randomized, Controlled Trial Of Apremilast, An Oral Phosphodiesterase 4 Inhibitor, In Patients With Psoriatic Arthritis and Current Skin Involvement (PALACE 3)44

Select a period of time:

Number of views in the range

Views
Long-Term (52-Week) Results Of a Phase 3, Randomized, Controlled Trial Of Apremilast, An Oral Phosphodiesterase 4 Inhibitor, In Patients With Psoriatic Arthritis and Current Skin Involvement (PALACE 3)33

Views

Views
March 20252
April 202512
May 20252
June 20251
July 20259
August 20252
September 20255
Download CSV file
 untranslated
 untranslated

Top country views

Views
Hong Kong10
United States9
Brazil6
Singapore2
United Kingdom2
Spain1
Italy1
Kenya1
Mexico1
 

Top cities views

Views
Hong Kong10
Council Bluffs3
Cajamar1
Contagem1
Durham1
Jackson1
Mexico City1
Mirante do Paranapanema1
Nairobi1
Osasco1